There are numerous medications that are used to manage complications associated with multiple sclerosis.
Among these, only dalfampridine (Ampyra®) has been approved by the FDA as a symptomatic (non-DMD) treatment for multiple sclerosis.The following table lists common complications, examples of drug and non-drug therapies, and comments about complications and/or management.Multiple sclerosis complications with examples of drug and non-drug management (this list is not exhaustive; most of the drugs listed below are used to treat multiple sclerosis symptoms even though they have not been FDA-approved for these particular purposes).